Drug Shortage Report for CASPOFUNGIN FOR INJECTION

Last updated on 2022-11-02 History
Report ID 169103
Drug Identification Number 02486997
Brand name CASPOFUNGIN FOR INJECTION
Common or Proper name CASPOFUNGIN FOR INJECTION
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CASPOFUNGIN
Strength(s) 70MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 70 mg
ATC code J02AX
ATC description ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-11-01
Actual start date 2022-11-01
Estimated end date 2023-01-23
Actual end date
Shortage status Actual shortage
Updated date 2022-11-02
Company comments We will be encountering a supply interruption on our Caspofungin for Injection 70 mg Vial 10 mL effective November 1, 2022 until January 23, 2023. Per our communication dated July 17, 2022, please note all current inventory of this product expires October 31, 2022.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-11-02 English Compare
v2 2022-09-12 French Compare
v1 2022-09-12 English Compare

Showing 1 to 3 of 3